NOVARTIS AG (NVS)
A+
Pipeline Grade
Drug Pipeline (104 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
ATRASENTAN HYDROCHLORIDE
VANRAFIA |
APPROVED | — |
|
OCTREOTIDE ACETATE
SANDOSTATIN |
APPROVED | — |
|
LAPATINIB DITOSYLATE
TYKERB |
APPROVED | — |
|
BETAXOLOL HYDROCHLORIDE
BETOPTIC S |
APPROVED | — |
|
OXCARBAZEPINE
TRILEPTAL |
APPROVED | — |
|
OFATUMUMAB
ARZERRA |
APPROVED | — |
|
PAZOPANIB HYDROCHLORIDE
VOTRIENT |
APPROVED | — |
|
FINGOLIMOD HYDROCHLORIDE
GILENYA |
APPROVED | — |
|
HYDROCHLOROTHIAZIDE, VALSARTAN
DIOVAN HCT |
APPROVED | — |
|
IPTACOPAN HYDROCHLORIDE
FABHALTA |
APPROVED | — |
|
INCLISIRAN SODIUM
LEQVIO |
APPROVED | — |
|
TRICLABENDAZOLE
EGATEN |
APPROVED | — |
|
ALPELISIB
VIJOICE |
APPROVED | — |
|
RIBOCICLIB SUCCINATE
KISQALI |
APPROVED | — |
|
TRAMETINIB DIMETHYL SULFOXIDE
MEKINIST |
APPROVED | — |
|
ASCIMINIB HYDROCHLORIDE
SCEMBLIX |
APPROVED | — |
|
TRAMETINIB
MEKINIST |
APPROVED | — |
|
SACUBITRIL, VALSARTAN
ENTRESTO SPRINKLE |
APPROVED | — |
|
BACLOFEN
LIORESAL |
APPROVED | — |
|
ELTROMBOPAG OLAMINE
PROMACTA KIT |
APPROVED | — |
|
DABRAFENIB MESYLATE
TAFINLAR |
APPROVED | — |
|
REMIBRUTINIB
RHAPSIDO |
APPROVED | — |
|
ARTEMETHER, LUMEFANTRINE
COARTEM |
APPROVED | — |
|
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
PLUVICTO |
APPROVED | — |
|
SIPONIMOD
MAYZENT |
APPROVED | — |
|
AMLODIPINE BESYLATE, VALSARTAN
EXFORGE |
APPROVED | — |
|
LETROZOLE, RIBOCICLIB SUCCINATE
KISQALI FEMARA CO-PACK (COPACKAGED) |
APPROVED | — |
|
BASILIXIMAB
SIMULECT |
APPROVED | — |
|
MYCOPHENOLATE SODIUM
MYFORTIC |
APPROVED | — |
|
AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE, VALSARTAN
EXFORGE HCT |
APPROVED | — |
|
OXPRENOLOL HYDROCHLORIDE
TRASICOR |
NDA | Acute Disseminated Encephalomyelitis, Acute Myeloid Leukemia, Adenocarcinoma, Advanced Breast Cancer, Age Related Macular Degeneration, Age Related Macular Degeneration (AMD), Anti-AMPAR-1/2 Associated Autoimmune Encephalitis, Anti-CASPR-2 Associated Autoimmune Encephalitis, Anti-GABAR-1/2 Associated Autoimmune Encephalitis, Anti-GAD65 Associated Autoimmune Encephalitis, Anti-Lgi-1 Associated Autoimmune Encephalitis, Anti-NMDAR Encephalitis, Asthma, Breast Cancer, Breast Cancer Recurrent, Cancer, Carcinoma, Carcinoma, Renal Cell, Chronic Idiopathic Urticaria, Chronic Myeloid Leukemia, Chronic Spontaneous Urticaria, Chronic Urticaria, Clear-cell Metastatic Renal Cell Carcinoma, CNS Lupus, CNS Sarcoidosis, CNS Vasculitis, COVID-19, Ewing's Sarcoma, Failure of Exactly One Prior VEGF-targeted Therapy, Fallopian Tube Neoplasms, Hashimoto Encephalitis, HER 2 Negative Breast Cancer, Her2-negative Locally Advanced Breast Cancer, Her2-negative Metastatic Breast Cancer, HER2/Neu-negative Carcinoma of Breast, High-grade |
|
DICLOFENAC SODIUM
VOLTAREN |
NDA | — |
|
FLUVASTATIN SODIUM
LESCOL |
NDA | — |
|
HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE
APRESAZIDE |
NDA | — |
|
PHENYLBUTAZONE
BUTAZOLIDIN |
NDA | — |
|
ACETYLDIGITOXIN
ACYLANID |
NDA | — |
|
MESORIDAZINE BESYLATE
SERENTIL |
NDA | — |
|
CHLORPHENIRAMINE MALEATE, PHENYLPROPANOLAMINE HYDROCHLORIDE
TRIAMINIC-12 |
NDA | — |
|
TERBINAFINE HYDROCHLORIDE
LAMISIL |
NDA | — |
|
TOLAZOLINE HYDROCHLORIDE
PRISCOLINE |
NDA | — |
|
CALCITONIN HUMAN
CIBACALCIN |
NDA | — |
|
CHLORTHALIDONE, METOPROLOL TARTRATE
LOPRESSIDONE |
NDA | — |
|
THIETHYLPERAZINE MALEATE
TORECAN |
NDA | — |
|
OXYPHENBUTAZONE
TANDEARIL |
NDA | — |
|
THIETHYLPERAZINE MALATE
TORECAN |
NDA | — |
|
RIVASTIGMINE TARTRATE
EXELON |
NDA | — |
|
PREDNISOLONE SODIUM PHOSPHATE, SULFACETAMIDE SODIUM
VASOCIDIN |
NDA | — |
|
HYDRALAZINE HYDROCHLORIDE, RESERPINE
SERPASIL-APRESOLINE |
NDA | — |
|
MAZINDOL
SANOREX |
NDA | — |
|
TRIPELENNAMINE HYDROCHLORIDE
PBZ |
NDA | — |
|
FLUMETHASONE PIVALATE
LOCORTEN |
NDA | — |
|
GLYCOPYRROLATE, INDACATEROL MALEATE
UTIBRON NEOHALER |
NDA | — |
|
SULFINPYRAZONE
ANTURANE |
NDA | — |
|
THIORIDAZINE
MELLARIL-S |
NDA | — |
|
DEXAMETHASONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE
DEXACIDIN |
NDA | — |
|
HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, RESERPINE
SER-AP-ES |
NDA | — |
|
CLOFAZIMINE
LAMPRENE |
NDA | — |
|
ACETAMINOPHEN, CLEMASTINE FUMARATE, PSEUDOEPHEDRINE HYDROCHLORIDE
TAVIST ALLERGY/SINUS/HEADACHE |
NDA | — |
|
HYDROCHLOROTHIAZIDE, PINDOLOL
VISKAZIDE |
NDA | — |
|
CAFFEINE, ERGOTAMINE TARTRATE
CAFERGOT |
NDA | — |
|
ALISKIREN HEMIFUMARATE, AMLODIPINE BESYLATE
TEKAMLO |
NDA | — |
|
ALISKIREN HEMIFUMARATE, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE
AMTURNIDE |
NDA | — |
|
ALUMINUM HYDROXIDE, MAGNESIUM TRISILICATE
FOAMICON |
NDA | — |
|
THEOPHYLLINE SODIUM GLYCINATE
ASBRON |
NDA | — |
|
TELBIVUDINE
TYZEKA |
NDA | — |
|
TRAVOPROST
IZBA |
NDA | — |
|
PHENTOLAMINE MESYLATE
REGITINE |
NDA | — |
|
METOPROLOL FUMARATE
LOPRESSOR |
NDA | — |
|
METHIXENE HYDROCHLORIDE
TREST |
NDA | — |
|
FLUORESCEIN SODIUM
FUNDUSCEIN-25 |
NDA | — |
|
DESOXYCORTICOSTERONE ACETATE
PERCORTEN |
NDA | — |
|
CLEMASTINE FUMARATE
TAVIST |
NDA | — |
|
ALISKIREN HEMIFUMARATE, VALSARTAN
VALTURNA |
NDA | — |
|
TRIPELENNAMINE CITRATE
PBZ |
NDA | — |
|
ACETYLCHOLINE CHLORIDE
MIOCHOL |
NDA | — |
|
METOPROLOL TARTRATE
LOPRESSOR |
NDA | — |
|
MEPHENYTOIN
MESANTOIN |
NDA | — |
|
FAMCICLOVIR
FAMVIR |
NDA | — |
|
MAPROTILINE HYDROCHLORIDE
LUDIOMIL |
NDA | — |
|
CERITINIB
ZYKADIA |
NDA | — |
|
CARBACHOL
CARBASTAT |
NDA | — |
|
NAPHAZOLINE HYDROCHLORIDE
VASOCON |
NDA | — |
|
OXYPHENONIUM BROMIDE
ANTRENYL |
NDA | — |
|
DIHYDROERGOTAMINE MESYLATE, HEPARIN SODIUM, LIDOCAINE HYDROCHLORIDE
EMBOLEX |
NDA | — |
|
GUANETHIDINE MONOSULFATE, HYDROCHLOROTHIAZIDE
ESIMIL |
NDA | — |
|
NATEGLINIDE
STARLIX |
NDA | — |
|
LEVOCABASTINE HYDROCHLORIDE
LIVOSTIN |
NDA | — |
|
PREDNISOLONE ACETATE, SULFACETAMIDE SODIUM
VASOCIDIN |
NDA | — |
|
ALSEROXYLON
RAUTENSIN |
NDA | — |
|
GUANETHIDINE MONOSULFATE
ISMELIN |
NDA | — |
|
INDACATEROL MALEATE
ARCAPTA NEOHALER |
NDA | — |
|
FOMIVIRSEN SODIUM
VITRAVENE PRESERVATIVE FREE |
NDA | — |
|
METHYSERGIDE MALEATE
SANSERT |
NDA | — |
|
THIORIDAZINE HYDROCHLORIDE
MELLARIL |
NDA | — |
|
HYDROCHLOROTHIAZIDE, TRIAMTERENE
TRIAMTERENE AND HYDROCHLOROTHIAZIDE |
NDA | — |
|
EMEDASTINE DIFUMARATE
EMADINE |
NDA | — |
|
AMINOGLUTETHIMIDE
CYTADREN |
NDA | — |
|
PINDOLOL
VISKEN |
NDA | — |
|
DESOXYCORTICOSTERONE PIVALATE
PERCORTEN |
NDA | — |
|
DESLANOSIDE
CEDILANID-D |
NDA | — |
|
DIBUCAINE HYDROCHLORIDE
HEAVY SOLUTION NUPERCAINE |
NDA | — |
|
ANTAZOLINE PHOSPHATE, NAPHAZOLINE HYDROCHLORIDE
VASOCON-A |
NDA | — |
|
LYPRESSIN
DIAPID |
NDA | — |
|
LODOXAMIDE TROMETHAMINE
ALOMIDE |
NDA | — |
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2027-07-01 | Phase3 Readout | — |
Active Clinical Trials (7)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT05918666 | National Register of Actionable Mutations | OTHER | Active Not Recruiting | 2,098 |
| NCT05009160 | DreaMS - Validation Study 1 | OTHER | Active Not Recruiting | 300 |
| NCT03349801 | Development of Novel Clinical Endpoints in Intermediate AMD | OTHER | Active Not Recruiting | 718 |
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients | OTHER | Recruiting | 12,400 |
| NCT05017142 | Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) | OTHER | Recruiting | 500 |
| NCT04671693 | A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Sur... | OTHER | Active Not Recruiting | 500 |
| NCT04111978 | MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | PHASE3 | Recruiting | 540 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.